Clinical Trial Update: Safety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002) [EARLY_Phase 1]

View source ↗

Summary

An early-phase safety and efficacy study of the Parkinson's disease gene therapy BBM-P002 has completed (Phase 1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BBM-P002

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Parkinson's Disease | EARLY_Phase 1 | Status: COMPLETED